WO2015048945A1 - Agents de traitement capillaire à performances améliorées - Google Patents

Agents de traitement capillaire à performances améliorées Download PDF

Info

Publication number
WO2015048945A1
WO2015048945A1 PCT/DE2014/200063 DE2014200063W WO2015048945A1 WO 2015048945 A1 WO2015048945 A1 WO 2015048945A1 DE 2014200063 W DE2014200063 W DE 2014200063W WO 2015048945 A1 WO2015048945 A1 WO 2015048945A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
carnitine
glu
hair
hair treatment
Prior art date
Application number
PCT/DE2014/200063
Other languages
German (de)
English (en)
Inventor
Erik Schulze Zur Wiesche
Melanie Giesen
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to DE112014004534.9T priority Critical patent/DE112014004534A5/de
Publication of WO2015048945A1 publication Critical patent/WO2015048945A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • the invention relates to hair treatment compositions, in particular so-called conditioners, with a combination of active ingredients for gentle and effective hair care.
  • the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • this treatment improves the combability, the hold and the fullness of the hair and reduces the splitting rate.
  • WO2010 / 026010 A1 There, in particular, oligopeptides with the sequence Tyr-Glu
  • Glu-Glu-Ile-Arg-Val-Leu is particularly suitable for hair care.
  • Purine derivatives are also often used in hair treatment compositions, e.g. described in EP 1 996 150 A1.
  • pea extracts to stimulate hair follicles is disclosed in FR 2 971 159 A1, and its antioxidant activity is also described, e.g. in EP 2 588 075 A1.
  • L-carnitine and / or certain carnitine derivatives and certain oligopeptides enhance their positive effect on the hair and the hair follicle.
  • a first subject of the present invention are hair treatment compositions containing - in each case based on their weight - a) 0.0001 to 10 wt .-% of at least one oligopeptide, the at least one amino acid sequence Glu-Glu-Glu
  • amino group may be free or protonated and the carboxy groups may be free or deprotonated
  • Carnitine and in particular L-carnitine tartrate are Carnitine and in particular L-carnitine tartrate.
  • the parenthetized hydrogen atom of the amino group, as well as the parenthetical group of the acid function means that the groups concerned may be present as such (then an oligopeptide having the relevant number of amino acids as shown (in the above) Formula) or that the amino acid sequence is present in an oligopeptide, which comprises more amino acids - depending on where the other (s) amino acid (s) is / are bound, the parent compound of the above formula by the / the other amino acid residue
  • hair treatment compositions are, for example, hair shampoos, hair conditioners, conditioning shampoos, hair sprays, hair rinses, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hair styling preparations, hair waving compositions.
  • agents according to the invention are preferably agents which the man applies anyway.
  • Preferred agents according to the invention are therefore shampoos, conditioners or hair tonics.
  • the hair treatment compositions according to the invention contain, by weight, 0.0001 to 10% by weight of at least one oligopeptide containing at least one amino acid residue Glu-Glu-Glu, i. has at least three consecutive glutamic acids.
  • Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids
  • the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, particularly preferably 7 to 12 amino acids and in particular 8, 9 or 10 amino acids.
  • Hair treatment compositions preferred according to the invention are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • preferred hair treatment compositions according to the invention are characterized in that the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids and a molecular weight of 650 to 3000 Da, preferably 750 to 2500 Da, more preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • oligopeptides which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence.
  • These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred in the present invention.
  • the oligopeptides used in the agents according to the invention contain no methionine. It is further preferred if the oligopeptides used in the agents according to the invention contain no cysteine and / or cystine. It is further preferred if the oligopeptides used in the agents according to the invention contain no aspartic acid and / or asparagine. It is further preferred if the oligopeptides used in the agents according to the invention contain no serine and / or threonine. In contrast, it is preferred if the oligopeptides used in the agents according to the invention contain tyrosine. It is further preferred if the oligopeptides used in the agents according to the invention contain leucine.
  • the oligopeptides used in the agents according to the invention contain isoleucine. It is further preferred if the oligopeptides used in the agents according to the invention contain arginine. It is further preferred if the oligopeptides used in the agents according to the invention contain valine. Particularly preferred oligopeptides or amino acid sequences contained in the preferred oligopeptides are described below:
  • a particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence.
  • Hair treatment compositions which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, where the amino group may be free or protonated and the carboxy groups may be free or deprotonated.
  • Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function.
  • Hair treatment compositions which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, where the amino- Group free or protonated and the carboxy groups may be free or deprotonated. Oligopeptides which have both the abovementioned amino acids (tyrosine and isoleucine) are preferred according to the invention. Hair treatment agents according to the invention in which the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile are particularly preferred, the amino group being free or protonated and the carboxy groups being free or deprotonated.
  • oligopeptides additionally contain arginine, which is preferably bound to isoleucine
  • Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine.
  • Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated can.
  • Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine.
  • Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated may be present.
  • Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine.
  • Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
  • compositions according to the invention containing at least two oligopeptides which satisfy the abovementioned criteria but differ from one another.
  • hair treatment agents containing at least two mutually different oligopetides A and B, both containing the amino acid sequence Glu-Glu-Glu are preferred.
  • Such mutually different oligopeptides A and B correspond to each other in that they carry three consecutive Glu amino acids in their amino acid sequence, but have differences in the upstream or downstream amino acids. Preference is given to mutually different peptides with partial agreement, which may well be greater than in the above-mentioned three amino acids.
  • hair treatment compositions are characterized by containing at least two mutually different oligopetides A and B, both containing the amino acid sequence Glu-Glu-Glu-Ile.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu.
  • Still further preferred hair treatment agents are characterized by containing at least two mutually different oligopetides A and B both containing the amino acid sequence Glu-Glu-Glu-Ile-Arg.
  • Even more preferred hair treatment agents contain at least two mutually different oligopetides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile.
  • Very particularly preferred hair treatment compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg.
  • very particularly preferred hair treatment compositions contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg.
  • hair treatment compositions containing at least two distinct oligopetides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val are further preferred embodiments of the present invention.
  • hair treatment compositions containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val.
  • Still further preferred hair treatment compositions according to the invention contain at least two mutually different oligopetides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • Still further preferred hair treatment agents contain at least two mutually different oligopetides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • Particularly preferred hair treatment compositions are characterized by containing at least two mutually different oligopetides A and B, wherein the oligopeptide A has the amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups may be free or deprotonated and the oligopeptide B has the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
  • Very particularly preferred agents of this last-mentioned embodiment contain, based on the weight of the composition, 0.00001 to 1% by weight of oligopeptide A and 0.00001 to 1% by weight of oligopeptide B.
  • compositions contain - based on the weight of the composition -0.00005 to 0, 1 wt .-% oligopeptide A and 0.00005 to 0.1 wt .-% Oligopeptide B.
  • Still further preferred agents of this latter embodiment contain, based on the weight of the agent, from 0.0001 to 0.01% by weight of oligopeptide A and from 0.0001 to 0.001% by weight of oligopeptide B.
  • compositions of the invention impart more resilience to the hairs treated with them, resulting in higher tensile strengths of the keratin fibers and a reduction in elasticity loss, e.g. when damaged by atmospheric agents.
  • particularly preferred oligopeptides also stabilize the moisture balance of the keratinischen
  • Fibers so that the combability improves and the aging process is delayed.
  • compositions of the present invention is that the moldability and restructurability of keratinic fibers treated with them is improved.
  • oligopeptides used in the context of the present invention which satisfy the abovementioned conditions, can advantageously be obtained from keratinic materials. It is preferred according to the invention that these oligopeptides are used in high proportions, based on the total keratinic peptide content of the agents.
  • the highest possible proportion of all the keratinic peptides contained in the agent satisfy the abovementioned conditions.
  • Preferred hair treatment compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, particularly preferably at least 1% by weight, more preferably at least 2.5% by weight, is even more preferred at least 5% by weight, and in particular at least 10% by weight, of all the keratinic peptides contained in the composition have the amino acid sequence Glu-Glu-Glu.
  • compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, more preferably at least 1% by weight, more preferably at least 2.5% by weight, still further preferably at least 5% by weight and in particular at least 10% by weight of all the keratinic peptides contained in the middle have the amino acid sequence Glu-Glu-Glu-Ile.
  • Still further preferred hair treatment compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, more preferably at least 1% by weight, more preferably at least 2.5% by weight, still more preferably at least 5% by weight and in particular at least 10% by weight of all the keratinic peptides contained in the middle have the amino acid sequence Tyr-Glu-Glu-Glu.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, more preferably at least 1% by weight, more preferably at least 2.5% by weight, still further preferably at least 5% by weight and in particular at least 10% by weight of all the keratinic peptides contained in the middle have the amino acid sequence Tyr-Glu-Glu-Glu-Ile.
  • Very particularly preferred hair treatment compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, more preferably at least 1% by weight, more preferably at least 2.5% by weight, still more preferably at least 5% by weight and in particular at least 10% by weight of all the keratinic peptides contained in the middle have the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg.
  • Still further preferred hair treatment compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, more preferably at least 1% by weight, more preferably at least 2.5% by weight, still more preferably at least 5% by weight and in particular at least 10% by weight of all the keratinic peptides contained in the middle have the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that at least 0.1% by weight, preferably at least 0.5% by weight, more preferably at least 1% by weight, more preferably at least 2.5% by weight, still further preferably at least 5% by weight and in particular at least 10% by weight of all the keratinic peptides contained in the middle have the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • the abovementioned conditions relate to the total content of the agents according to the invention to peptides which originate from keratinic materials.
  • oligopeptides of keratinic origin of course, other peptides and / or protenihydrolysates can be used, for example from other native sources.
  • wheat protein hydrolysates is preferred, see below.
  • the hair treatment compositions according to the invention contain as the second essential ingredient - based on their weight - 0.0001 to 10 wt .-% of at least one compound selected from L-carnitine, and / or the carnitine derivatives acetyl-L-carnitine, L-carnitine fumarate, L Carnitine citrate, lauroyl L-carnitine and especially L-carnitine tartrate.
  • compositions according to the invention may contain L-carnitine and / or an L-carnitine derivative or else a plurality of different L-carnitine derivatives.
  • L-carnitine or L-carnitine derivatives are contained in the agents according to the invention preferably in amounts of 0.001 to 10 wt .-%, based on the total preparation. Levels of 0.1 to 10 wt% are particularly preferred, amounts of 0.1 to 5 wt% are particularly preferred, and amounts of 1 to 3 wt% are most preferred.
  • Particularly preferred hair treatment agents are characterized in that they contain 0.0005 to 7.5% by weight, preferably 0.001 to 6% by weight, more preferably 0.005 to 5% by weight, more preferably 0.01 to 4% by weight. % and in particular 0.1 to 3 wt .-% of at least one compound selected from L-carnitine, and / or the carnitine derivatives acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and especially L-carnitine tartrate.
  • preferred hair-treatment compositions contain - in each case based on their weight - 0.0002 to 5 wt .-%, preferably 0.0005 to 2.5 wt .-%, more preferably 0.00075 to 1 wt .-%, particularly preferably 0.001 to 0.5% by weight, more preferably 0.002 to 0.25 Wt .-% and in particular 0.005 to 0, 1 wt .-% oligopeptide (s) with the
  • Wt .-% more preferably 0.01 to 4 wt .-% and in particular 0, 1 to 3 wt .-% L-
  • compositions according to the invention can be increased still further, in particular with regard to the positive effects on the hair roots and the inner structural strengthening of the keratin fibers, if the compositions contain purine or purine derivatives.
  • Hair treatment agents preferred according to the invention are characterized in that they contain 0.0005 to 7.5% by weight, preferably 0.001 to 6% by weight, more preferably 0.005 to 5% by weight, more preferably 0.01 to 4% by weight. % and in particular 0, 1 to 3 wt .-% purine and / or purine derivative (s) of the formula (I)
  • radicals R, R 2 and R 3 are independently selected from -H, -OH, -NH 2, -SH and the radicals R 4 , R 5 and R 6 are selected independently of one another from -H, -CH 3 and - CH 2 -CH 3, the following compounds being preferred:
  • Preferred agents according to the invention contain purine and / or purine derivatives in narrower quantitative ranges.
  • preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1 wt .-% purine (s) and / or purine derivative (s).
  • Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos and conditioners, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the agent) can be used.
  • preferred hair treatment compositions contain - each based on their weight
  • oligopeptide (s) having the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val wherein the amino groups are free or protonated and the Carboxy groups may be free or deprotonated,
  • compositions contain extracts of peas (Pisum sativum).
  • Hair treatment agents preferred according to the invention contain from 0.0005 to 7.5% by weight, preferably from 0.001 to 6% by weight, more preferably from 0.005 to 5% by weight, more preferably from 0.01 to 4% by weight and in particular 0, 1 to 3 wt .-% of at least one extract of Pisum sativium. It is highly preferred that all of the above conditions be satisfied simultaneously.
  • Particularly preferred hair treatment compositions according to the invention contain - in each case based on their weight
  • oligopeptide (s) having the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val wherein the amino groups are free or protonated and the Carboxy groups may be free or deprotonated,
  • 0.001 to 2.5 wt .-% preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1 wt .-% caffeine,
  • the agents according to the invention may contain further active ingredients and adjuvants. These are described below.
  • the agents according to the invention preferably additionally comprise at least one emulsifier or a surfactant, surface-active substances being referred to as surfactants or as emulsifiers, depending on the field of use, and selected from anionic, cationic, zwitterionic, ampholytic and nonionic surfactants and emulsifiers.
  • Hair treatment compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.5 to 70% by weight, preferably from 1 to 60% by weight and in particular from 5 to 25% by weight of anionic and / or nonionic (s) and / or cationic and / or amphoteric surfactant (s).
  • Zwitterionic surfactants and emulsifiers are those surface-active compounds which carry at least one quaternary ammonium group and at least one COO () or -SO 3 () group in the molecule.
  • Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3 carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group, and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty
  • Ampholytic surfactants and emulsifiers are understood as meaning those surface-active compounds which, apart from a Cs-C24-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SCbH group and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C12-C18 acylsarcosine.
  • Nonionic surfactants and emulsifiers contain as hydrophilic group z.
  • cationic surfactants of the quaternary ammonium compound type are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides.
  • the long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as.
  • cetyltrimethylammonium chloride stearyltrimethylammonium chloride, distearyldimethyl ammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride.
  • Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • compositions according to the invention which additionally contain fatty alcohol (s) and / or fatty alcohol alkoxylate (s), preferably C 12-22 fatty alcohol (s) and / or C 12-22 fatty alcohol ethoxylate (s) having 10 to 30 EO units, especially preferably Ci6-is fatty alcohol (s) and / or C16-18 fatty alcohol ethoxylate (s) having 12 to 20 EO units, preferably in amounts of 5 to 20 wt .-%, preferably from 7.5 to 17.5 wt .-% and in particular from 10 to 15 wt .-%, each based on the weight of the composition.
  • hair-treatment compositions according to the invention contain, by weight, from 0.1 to 20% by weight, preferably from 0.25 to 17.5% by weight and in particular from 5 to 15% by weight of anionic surfactant ( e), particularly preferably fatty alcohol ether sulfates of the formula
  • n represents values of from 5 to 21, preferably from 7 to 19, particularly preferably from 9 to 17 and in particular from 1 to 13 and k for values of 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, preferably represent 1, 2 or 3 and especially 2
  • M is a cation selected from the group Na +, K + NH4 +, Mg 2+, Zn 2+ 14, preferably Na + are, ,
  • Preferred hair treatment agents according to the invention are further characterized in that they additionally contain amphoteric surfactant (s), preferably from the groups of N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N Alkyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic acids each having about 8 to 24 carbon atoms in the alkyl group, alkylaminoacetic acids each having about 8 to 24 carbon atoms in the alkyl group, N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate C12 - C18 acylsarcosine, N- Alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium gly
  • the agents according to the invention may contain from 0.01 to 10% by weight of at least one polymer from the group of cationic and / or amphoteric polymers.
  • Cationic or amphoteric polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • "permanently cationic” refers to those polymers which regardless of the pH of the agent have a cationic group. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • the agents according to the invention can also contain amphoteric polymers. These additionally have at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers.
  • the polymer or polymers are used within narrower ranges.
  • compositions according to the invention which, based on their weight, are from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight, particularly preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of amphoteric polymer (s).
  • agents contain amphoteric polymers or not
  • further preferred agents according to the invention are characterized in that they contain 0.05 to 7.5% by weight, preferably 0.1 to 5% by weight, based on their weight. -%, particularly preferably 0.2 to 3.5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) polymer (s) included.
  • hair-treatment compositions according to the invention are preferred which, based on their weight, are from 0.05 to 7.5% by weight, preferably from 0 to 1 to 5% by weight, particularly preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of cationic polymer (s), preferred cationic polymer (s) being / are selected from
  • Poly (methacryloyloxyethyltrimethylammoniumchlorid) (INCI: Polyquaternium-37) and / or quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or cationic alkylpolyglycosides and / or cationised honey and / or cationic guar derivatives and / or polymeric dimethyldiallylammonium salts and copolymers thereof
  • the agents of the invention may contain amphoteric polymers.
  • the agents according to the invention may with particular preference contain one or more amino acids.
  • Particularly preferred amino acids which can be used according to the invention are from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, ⁇ Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine
  • Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges.
  • preferred hair treatment compositions are characterized in that they as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1, 5 Wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0, 1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.
  • compositions of the invention are vitamins, provitamins or vitamin precursors. These are described below:
  • vitamin A includes retinol (vitamin Ai) and 3,4-didehydroretinol (vitamin A2).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • hair treatment compositions according to the invention are preferred which additionally contain as care substance - based on its weight - 0.1 to 5 wt .-%, preferably 0.2 to 4 wt .-%, particularly preferably 0.25 to 3.5 wt .-% , more preferably 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or pro-vitamins and / or vitamin precursors containing, preferably, the groups A, B, C, E, Panthenol (( ⁇ ) -2,4-dihydroxy-A / - (3-hydroxypropyl) -3,3-dimethylbutyramide, provitamin Bs) and / or pantothenic acid (vitamin B3, vitamin Bs) and / or niacin, niacinamide or nicotinamide (vitamin B3) and / or L-ascorbic acid (vitamin C) and / or thiamine (vitamin B1) and
  • compositions according to the invention may contain purine and / or purine derivatives.
  • purine and / or purine derivatives with ubiquinones and / or plastoquinones results in that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.
  • the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides.
  • preferred hair treatment compositions according to the invention characterized in that they as Nursing material - based on its weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt .-%, more preferably 0.5 to 3, 5 wt .-% and in particular 0.75 to 2.5 wt .-% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides, preferred carbohydrates are selected from Monosachhariden, in particular D-ribose and / or D.
  • Xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L-fucose and / or L-rhamnose disaccharides in particular sucrose and / or maltose and / or lactose and / or trehalose and / or cellobiose and / or gentiobiose and / or isomaltose.
  • Particularly preferred agents according to the invention contain based on their weight
  • preferred agents according to the invention contain (a) amino acid (s).
  • Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges.
  • preferred cosmetic compositions according to the invention are characterized in that they additionally contain from 0.05 to 5% by weight, preferably from 0.1 to 2.5% by weight, more preferably from 0 to 15% by weight and in particular from 0 to 15% by weight , 2 to 0.5 wt .-% amino acid (s), preferably (one) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.
  • Particularly preferred agents according to the invention contain based on their weight
  • Agents preferred according to the invention contain as care substance - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7.5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur I) and / or of the formula (Fur-II)
  • R as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di or trihydroxyhydrocarbyl radical,
  • R 2 and R 3 are each independently of one another hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
  • R 4 is hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di - or triamine hydrocarbon residue,
  • R 5 and R 6 each represent hydrogen, methyl, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triamine hydrocarbon radical,
  • R 6 represents a methyl, a C 2 -C 4 saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated one , branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a --C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triamine hydrocarbon radical,
  • R 7 represents a methyl, a C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxy hydrocarbon radical, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical,
  • preferred hair-treatment compositions contain as care substance - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7.5% by weight and in particular 0.5 to 5% by weight of taurine (2-aminoethanesulfonic acid).
  • hair treatment compositions according to the invention are preferred which additionally contain 0.001 to 5 wt .-%, preferably 0.01 to 4 wt .-%, particularly preferably 0.02 to 2.5 wt .-% and in particular 0, 1 to 1, 5 wt % Bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol.
  • compositions of the invention may contain, in addition to the oligopeptide (s), the carnitine derivative (s) and optional other ingredients, other substances that prevent, ameliorate or cure hair loss.
  • oligopeptide s
  • carnitine derivative s
  • optional other ingredients other substances that prevent, ameliorate or cure hair loss.
  • a content of hair root stabilizing agents is advantageous.
  • Propecia (finasteride) is currently the only product approved worldwide that has been proven efficacy and tolerability in numerous studies. Propecia causes less DHT to form from testosterone.
  • Minoxidil is probably the oldest proven hair restorer with or without supplemental additives. For the treatment of hair loss, it may only be used for external application. There are hair lotions containing 2% -5% minoxidil, as well as gels with up to 15% minoxidil. The effectiveness increases with the dosage, in hair waters Minoxidil is only up to 5% share soluble. In many countries, hair tonic with up to 2% minoxidil content is available without prescription.
  • spironolactone in the form of hair tonic and in combination with minoxidil can be used for external application.
  • Spironolactone acts as an androgen receptor blocker, ie. the binding of DHT to the hair follicles is prevented.
  • cosmetic agents according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.
  • Additional antidandruff active ingredients for example climbazole, piroctone olamine or zinc pyrithione
  • climbazole, piroctone olamine or zinc pyrithione are used to purposefully reduce the amount of dandruff causing the dandruff, to restore the normal bacterial count to the normal percentage and to reduce the scaling to the physiological level.
  • laboratory tests have shown that the different species representatives of Pityrosporum ovale react differently to the antidandruff active ingredients. In order to maximally combat all dandruff is therefore a combination of anti-dandruff active ingredients most successful.
  • hair treatment compositions according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of antidandruff active ingredients, in particular piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-tri-methylpentyl) -pyridine-2 ( 1 H) -one, compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or selenium sulfide and / or climbazole and / or salicylic acid or fumaric acid.
  • antidandruff active ingredients in particular piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-tri-methylpentyl) -pyridine-2 ( 1 H) -one, compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or selenium sulfide and / or climbazole and / or salicylic acid or fumaric acid.
  • compositions according to the invention may furthermore contain all active substances, additives and auxiliaries known for such preparations.
  • the agents contain at least one surfactant, wherein in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable.
  • anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable.
  • the agents according to the invention may contain emulsifiers (F).
  • Emulsifiers effect at the phase interface the formation of water- or oil-stable adsorption layers, which protect the dispersed droplets against coalescence and thus stabilize the emulsion.
  • Emulsifiers are therefore constructed like surfactants from a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions.
  • An emulsion is to be understood as meaning a droplet-like distribution (dispersion) of a liquid in another liquid under the expense of energy in order to create stabilizing phase interfaces by means of surfactants.
  • the selection of these emulsifying surfactants or emulsifiers depends on the substances to be dispersed and the respective outer phase and the fineness of the emulsion.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • compositions according to the invention may preferably contain at least one nonionic emulsifier having an HLB value of 8 to 18.
  • Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention. It has furthermore proven to be advantageous if, in addition to the polymer (s) from the group of cationic and / or amphoteric polymers, further polymers (G) are contained in the agents according to the invention. In a preferred embodiment, therefore, further polymers are added to the compositions according to the invention, both anionic and nonionic polymers having proven effective.
  • the preparations comprise a plurality of, in particular two, different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.
  • the other polymers (G) are contained in the agents according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0, 1 to 5, in particular from 0, 1 to 3 wt .-%, are particularly preferred.
  • an agent according to the invention may also contain UV filters (I).
  • the UV filters to be used according to the invention are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum is in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC ( ⁇ 280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.
  • the UV filters (I) are usually contained in the agents according to the invention in amounts of 0.1-5% by weight, based on the total agent. Levels of 0.4-2.5 wt .-% are preferred.
  • compositions of the invention may further contain a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • a 2-pyrrolidinone-5-carboxylic acid and its derivatives Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three O to C4-alkyl groups.
  • the sodium salt is most preferred.
  • the amounts used in the compositions according to the invention are preferably from 0.05 to 10% by weight, based on the total composition, particularly preferably from 0.1 to 5, and in particular from 0.1 to 3,% by weight.
  • compositions according to the invention may also contain plant extracts (L).
  • extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant.
  • extractant for the preparation of said plant extracts water, alcohols and Al mixtures thereof can be used.
  • alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred. Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
  • compositions according to the invention mixtures of several, especially two, different plant extracts.
  • a particularly preferred group of ingredients are the silicones.
  • Silicone preferably a silicone, which is selected from:
  • polyalkyl siloxanes polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
  • grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone to which at least one polysiloxane macromer has been grafted in the chain and optionally at least one chain end; (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;
  • compositions according to the invention comprise the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5% by weight. , in each case based on the total mean.
  • x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
  • silicones are called DIMETHICONE according to the INCI nomenclature.
  • the compounds are preferably:
  • compositions of the invention may be included in the compositions of the invention.
  • Preferred silicones can be used according to the invention have viscosities at 20 ° C of 0.2 to 2 mm 2 s _, wherein silicones with viscosities of from 0.5 to 1 mm 2 s are particularly preferred _.
  • Particularly preferred agents according to the invention contain one or more amino-functional silicones.
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)
  • m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.
  • compositions according to the invention which are an amino-functional silicone of the formula (Si-IIb)
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • agents according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g, are preferred ,
  • the amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • Agents preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and in particular 0, 5 to 5 wt.% Amino-functional silicone (s) included.
  • CYCLOMETHICONE The cydic dimethicones designated as CYCLOMETHICONE according to INCI are also preferably used according to the invention.
  • agents according to the invention are preferred which contain at least one silicone of the formula Si-III
  • x is a number from 3 to 200, preferably from 3 to 10, more preferably from 30 to 7 and in particular 3, 4, 5 or 6.
  • the silicones described above have a backbone composed of -Si-O-Si units. Of course, these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are accessible by chain extension reactions and are preferably used in the form of silicone-in-water emulsions. Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula Si-IV
  • R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the Ci-20-alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3, -CH 2 CH (CH 3 ) 2, -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 ) 3 , x and y represent a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10, preferably from 1 to 8 and especially for 2, 3, 4, 5, 6 stands.
  • the silicones are preferably water-soluble. Agents preferred according to the invention are characterized in that they contain at least one water-soluble silicone. 02/13/2014
  • the NTU (Nephelometry Turbidity Unit) value is a fluid turbidity measurement unit used in water treatment and is the unit of turbidity of a fluid measured with a calibrated nephelometer.
  • compositions according to the invention have advantageous properties and also confer advantageous properties on the hair treated with them.
  • hair and scalp treatment benefits have been observed bvzw the advantages of the oligopeptides.
  • Hyaluronic acid ester go out alone.
  • hair treatment compositions according to the invention increase the elasticity of the hair treated with them and lead to an inner-structural strengthening of the hair fibers, which is e.g. reflected in higher melting temperatures in differential thermal analysis.
  • compositions according to the invention cause an increase in the elasticity and, surprisingly, sebum-regulating effects. The visual impression of "greasy" skin or hair is thus avoided or weakened.
  • Another object of the present invention is a method for improving at least one of the properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention a pour objet des agents de traitement capillaire renfermant - respectivement, par rapport à leur poids - 0,0001 à 10 % en poids d'au moins un oligopeptide qui présente au moins une séquence aminoacide Glu-Glu-Glu de formule (I), le groupe amino étant libre ou protoné et les groupes carboxy pouvant être libres ou déprotonés, et 0,0001 à 10 % en poids d'au moins un composé choisi dans le groupe constitué par la L-carnitine et/ou les dérivés de carnitine acétyl-L-carnitine, L-carnitine-fumarate, L-carnitine-citrate, lauroyl-L-carnitine et, en particulier, L-carnitine-tartrate. Dans ces agents, la L-carnitine et/ou les dérivés de carnitine et des oligopeptides déterminés se renforcent dans leur action positive sur le cheveu et les follicules pileux.
PCT/DE2014/200063 2013-10-01 2014-02-14 Agents de traitement capillaire à performances améliorées WO2015048945A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE112014004534.9T DE112014004534A5 (de) 2013-10-01 2014-02-14 Leistungsgesteigerte Haarbehandlungsmittel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013219920.1A DE102013219920A1 (de) 2013-10-01 2013-10-01 leistungsgesteigerte Haarbehandlungsmittel
DE102013219920.1 2013-10-01

Publications (1)

Publication Number Publication Date
WO2015048945A1 true WO2015048945A1 (fr) 2015-04-09

Family

ID=50513628

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2014/200063 WO2015048945A1 (fr) 2013-10-01 2014-02-14 Agents de traitement capillaire à performances améliorées

Country Status (2)

Country Link
DE (2) DE102013219920A1 (fr)
WO (1) WO2015048945A1 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539088A1 (fr) 2002-09-19 2005-06-15 Henkel Kommanditgesellschaft auf Aktien Soin pour les cheveux comprenant une combinaison de substances actives aux liposomes
WO2008028895A1 (fr) 2006-09-06 2008-03-13 Henkel Ag & Co. Kgaa Diminution du vieillissement capillaire
EP1996150A1 (fr) 2006-03-07 2008-12-03 Henkel AG & Co. KGaA Agents cosmétiques contenant de la purine et/ou des dérivés i de purine
WO2010026010A2 (fr) 2008-09-03 2010-03-11 Henkel Ag & Co. Kgaa Agents de traitement capillaire comprenant des oligopeptides faiblement dosés
WO2011042323A2 (fr) * 2009-10-05 2011-04-14 Henkel Ag & Co. Kgaa Agents de traitement capillaire contenant un ou plusieurs tensioactifs et un ou plusieurs protéolipides
WO2012084336A2 (fr) * 2010-12-21 2012-06-28 Henkel Ag & Co. Kgaa Agents de traitement capillaire contenant un ou plusieurs tensioactifs et un ou plusieurs hydrolysats de kératine cationiques
FR2971159A1 (fr) 2011-02-03 2012-08-10 Silab Sa Utilisation cosmetique d'un principe actif agissant sur les cellules souches cutanees, principe actif utilise et procede d'obtention d'un principe actif adapte
EP2588075A2 (fr) 2010-07-01 2013-05-08 ISP Investments Inc. Utilisation d'un extrait peptidique de pois en tant qu'agent actif antioxydant dans une composition cosmetique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539088A1 (fr) 2002-09-19 2005-06-15 Henkel Kommanditgesellschaft auf Aktien Soin pour les cheveux comprenant une combinaison de substances actives aux liposomes
EP1996150A1 (fr) 2006-03-07 2008-12-03 Henkel AG & Co. KGaA Agents cosmétiques contenant de la purine et/ou des dérivés i de purine
WO2008028895A1 (fr) 2006-09-06 2008-03-13 Henkel Ag & Co. Kgaa Diminution du vieillissement capillaire
WO2010026010A2 (fr) 2008-09-03 2010-03-11 Henkel Ag & Co. Kgaa Agents de traitement capillaire comprenant des oligopeptides faiblement dosés
US20130216490A1 (en) * 2008-09-03 2013-08-22 Henkel Ag & Co. Kgaa Hair treatment agents having low-dose oligopeptides
WO2011042323A2 (fr) * 2009-10-05 2011-04-14 Henkel Ag & Co. Kgaa Agents de traitement capillaire contenant un ou plusieurs tensioactifs et un ou plusieurs protéolipides
EP2588075A2 (fr) 2010-07-01 2013-05-08 ISP Investments Inc. Utilisation d'un extrait peptidique de pois en tant qu'agent actif antioxydant dans une composition cosmetique
WO2012084336A2 (fr) * 2010-12-21 2012-06-28 Henkel Ag & Co. Kgaa Agents de traitement capillaire contenant un ou plusieurs tensioactifs et un ou plusieurs hydrolysats de kératine cationiques
FR2971159A1 (fr) 2011-02-03 2012-08-10 Silab Sa Utilisation cosmetique d'un principe actif agissant sur les cellules souches cutanees, principe actif utilise et procede d'obtention d'un principe actif adapte

Also Published As

Publication number Publication date
DE112014004534A5 (de) 2016-06-16
DE102013219920A1 (de) 2015-04-02

Similar Documents

Publication Publication Date Title
EP2344116B1 (fr) Agents de traitement capillaire comprenant des oligopeptides faiblement dosés
EP2178497B1 (fr) Produits cosmétiques à base de chitosane et de silicones élastomères
EP2111852A2 (fr) Procédé de traitement pour le soin des cheveux
WO2010020516A1 (fr) Système de tensioactif doux sans sulfates pour le nettoyage de la peau et des cheveux
EP2164456B1 (fr) Produit de traitement capillaire avec oligopeptides
WO2009024360A1 (fr) Agents de traitement capillaire contenant un ou plusieurs tensioactifs et mélatonine/agomélatine
WO2012084336A2 (fr) Agents de traitement capillaire contenant un ou plusieurs tensioactifs et un ou plusieurs hydrolysats de kératine cationiques
WO2009024361A1 (fr) Agents de traitement capillaire contenant un ou plusieurs alcools et de la mélatonine/agomélatine
EP2841169B1 (fr) Produit de traitement capillaire contenant un (des) organopolysiloxane(s) à terminaison hydroxy et un (des) agent(s) épaississant(s)
WO2015048951A1 (fr) Agent de soin capillaire à performances améliorées
EP2391339B1 (fr) Produit de traitement capillaire pour le maintien de la couleur
WO2015048945A1 (fr) Agents de traitement capillaire à performances améliorées
WO2012055584A2 (fr) Agents de traitement capillaire comprenant du 3-méthyl-1,3-butanediol et un/des alkylpolyglycoside(s)
EP2370176A2 (fr) Agents de traitement capillaire comprenant des imidazolines et des diesters de l'éthylène glycol
DE102015216690A1 (de) Leistungsstarke Haarbehandlungsmittel mit einem Oligopeptid und einem Magnesiumsalz
WO2012055582A2 (fr) Agents de traitement capillaire comprenant du 3-méthyl-1,3-butanediol et un/des tensioactif(s) amphotère(s)
EP2238966A2 (fr) Shampooings doux et conditionneur pour le cuir chevelu
DE102008031205A1 (de) Verwendung von natürlichen 1,3-Diolen
DE102009028085A1 (de) Verwendung von Olivenöl und Proteinhydrolysaten in der Haarpflege
DE102013219916A1 (de) leistungsgesteigerte Haarbehandlungsmittel II
WO2012055583A2 (fr) Agents de traitement capillaire comprenant du 3-méthyl-1,3-butanediol et un/des tensioactif(s) anioniques(s)
EP3229921A1 (fr) Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu
DE102013220061A1 (de) Leistungsgesteigerte Haarbehandlungsmittel
EP2432446A2 (fr) Composition cosmétique et procédé de mise en forme pour des fibres kératiniques
WO2009083284A1 (fr) Stabilisation de produits de lavage pour cheveux

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14718316

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 112014004534

Country of ref document: DE

Ref document number: 1120140045349

Country of ref document: DE

REG Reference to national code

Ref country code: DE

Ref legal event code: R225

Ref document number: 112014004534

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14718316

Country of ref document: EP

Kind code of ref document: A1